PMID- 35886009 OWN - NLM STAT- MEDLINE DCOM- 20220728 LR - 20220928 IS - 2073-4425 (Electronic) IS - 2073-4425 (Linking) VI - 13 IP - 7 DP - 2022 Jul 9 TI - Unravelling the Distinct Effects of Systolic and Diastolic Blood Pressure Using Mendelian Randomisation. LID - 10.3390/genes13071226 [doi] LID - 1226 AB - A true discrepancy between the effect of systolic blood pressure (SBP) and diastolic blood pressure (DBP) on cardiovascular (CV) outcomes remains unclear. This study performed two-sample Mendelian randomization (MR) using genetic instruments that exclusively predict SBP, DBP or both to dissect the independent effect of SBP and DBP on a range of CV outcomes. Genetic predisposition to higher SBP and DBP was associated with increased risk of coronary artery disease (CAD), myocardial infarction (MI), stroke, heart failure (HF), atrial fibrillation (AF), chronic kidney disease (CKD) and type 2 diabetes mellitus (T2DM). Genetically proxied SBP exclusively was associated with CAD (OR 1.18, 95% CI: 1.03-1.36, per 10 mmHg), stroke (1.44[1.28-1.62]), ischemic stroke (1.49[1.30-1.69]), HF (1.41[1.20-1.65]), AF (1.28[1.15-1.43]), and T2DM (1.2[1.13-1.46]). Genetically proxied DBP exclusively was associated with stroke (1.21[1.06-1.37], per 5 mmHg), ischemic stroke (1.24[1.09-1.41]), stroke small-vessel (1.35[1.10-1.65]) and CAD (1.19[1.00-1.41]). Multivariable MR using exclusive SBP and DBP instruments showed the predominant effect of SBP on CAD (1.23[1.05-1.44], per 10 mmHg), stroke (1.39[1.20-1.60]), ischemic stroke (1.44[1.25-1.67]), HF (1.42[1.18-1.71]), AF (1.26[1.10-1.43]) and T2DM (1.31[1.14-1.52]). The discrepancy between effects of SBP and DBP on outcomes warrants further studies on underpinning mechanisms which may be amenable to therapeutic targeting. FAU - Le, Nhu Ngoc AU - Le NN AD - Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow G12 8TA, UK. FAU - Tran, Tran Q B AU - Tran TQB AD - Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow G12 8TA, UK. FAU - Lip, Stefanie AU - Lip S AD - Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow G12 8TA, UK. FAU - McCallum, Linsay AU - McCallum L AD - Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow G12 8TA, UK. FAU - McClure, John AU - McClure J AD - Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow G12 8TA, UK. FAU - Dominiczak, Anna F AU - Dominiczak AF AD - Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow G12 8TA, UK. FAU - Gill, Dipender AU - Gill D AUID- ORCID: 0000-0001-7312-7078 AD - Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London W2 1PG, UK. FAU - Padmanabhan, Sandosh AU - Padmanabhan S AUID- ORCID: 0000-0003-3869-5808 AD - Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow G12 8TA, UK. LA - eng PT - Journal Article DEP - 20220709 PL - Switzerland TA - Genes (Basel) JT - Genes JID - 101551097 SB - IM MH - *Atrial Fibrillation/genetics MH - Blood Pressure MH - *Diabetes Mellitus, Type 2/complications/genetics MH - *Heart Failure MH - Humans MH - *Hypertension/drug therapy MH - *Ischemic Stroke MH - *Stroke/genetics PMC - PMC9323763 OTO - NOTNLM OT - Mendelian randomization OT - blood pressure OT - diastolic OT - systolic COIS- D.G. is employed part-time by Novo Nordisk. The other authors report no conflict. EDAT- 2022/07/28 06:00 MHDA- 2022/07/29 06:00 PMCR- 2022/07/09 CRDT- 2022/07/27 01:17 PHST- 2022/06/21 00:00 [received] PHST- 2022/07/05 00:00 [revised] PHST- 2022/07/06 00:00 [accepted] PHST- 2022/07/27 01:17 [entrez] PHST- 2022/07/28 06:00 [pubmed] PHST- 2022/07/29 06:00 [medline] PHST- 2022/07/09 00:00 [pmc-release] AID - genes13071226 [pii] AID - genes-13-01226 [pii] AID - 10.3390/genes13071226 [doi] PST - epublish SO - Genes (Basel). 2022 Jul 9;13(7):1226. doi: 10.3390/genes13071226.